Code | 81325 | ||||||||||
MA number | EU/1/09/544/001 | ||||||||||
Product Form: | sol inj 2x200 mg/1 ml (striek.inj.napl.+2 lieh.tamp.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | UCB Pharma S.A. , Belgium | ||||||||||
Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | glass pre-filled syringe | ||||||||||
Route of admin.: | Subcutaneous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 01.10.2009 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 15.05.2019 |